B. Rzany

发表

S3 – Guidelines on the treatment of psoriasis vulgaris (English version). Update

H. Orzechowski, K. Reich, M. Sebastian, 2012, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

German S3-guidelines on the treatment of psoriasis vulgaris (short version)

H. Orzechowski, K. Reich, B. Rzany, 2012, Archives of Dermatological Research.

Efficacy of systemic therapies for moderate‐to‐severe psoriasis: a systematic review and meta‐analysis of long‐term treatment

J. Schmitt, B. Rzany, A. Nast, 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

S3 – Guidelines on the treatment of psoriasis vulgaris Update 2011

H. Orzechowski, K. Reich, M. Sebastian, 2011 .

European S3‐Guidelines on the systemic treatment of psoriasis vulgaris

L. Naldi, H. Hönigsmann, M. Hussain, 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version)

H. Orzechowski, K. Reich, B. Rzany, 2007, Archives of Dermatological Research.

Biological therapies in the systemic management of psoriasis: International Consensus Conference

J. Saurat, S. Chimenti, J. Ortonne, 2004, The British journal of dermatology.

Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany.

B. Rzany, B. Rzany, E. Schöpf, 1991, Archives of dermatology.

Reduction of unwanted submental fat with ATX-101 (deoxycholic acid), an adipocytolytic injectable treatment: results from a phase III, randomized, placebo-controlled study*

B. Rzany, B. Rzany, T. Griffiths, 2014, The British journal of dermatology.

Disclosure of potential conflicts of interest in dermatological guidelines in Germany – an analysis – status quo and quo vadis

A. Nast, B. Sporbeck, S. Rosumeck, 2011, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Evidence Based Medicine’s Perspective on Biologics

A. Nast, B. Rzany, 2007 .

Treatment of bullous pemphigoid with dapsone, methylprednisolone, and topical clobetasol propionate: a retrospective study of 62 cases.

E. Bröcker, D. Zillikens, M. Goebeler, 2005, Cutis.

Overview on Injectable Fillers: Efficacy and Safety

B. Rzany, 2014 .

Psoriasis (chronic plaque).

L. Naldi, B. Rzany, 2009, BMJ clinical evidence.

Translating psoriasis treatment guidelines into clinical practice - the need for educational interventions and strategies for broad dissemination.

A. Nast, D. Pathirana, R. Erdmann, 2008, Journal of evaluation in clinical practice.

Botulinum Toxin in Aesthetic Medicine

B. Rzany, M. Maio, 2007 .

Interventions for localised excessive sweating

B. Rzany, D. Spinner, 2000 .

Short version of the German evidence-based Guidelines for prophylactic vaccination against HPV-associated neoplasia.

P. Hillemanns, S. Smola, H. Pfister, 2009, Vaccine.

A critical appraisal of evidence‐based guidelines for the treatment of psoriasis vulgaris: ‘AGREE‐ing’ on a common base for European evidence‐based psoriasis treatment guidelines

A. Nast, B. Rzany, P. Saiag, 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

Risk factors for hypercreatinemia in patients with systemic lupus erythematosus

P. Whelton, J. Coresh, M. Petri, 1999, Lupus.

Epidemiology of Autoimmune Skin Disorders

B. Rzany, N. Weller, 2001 .

Evidence‐based (S3) guidelines for the treatment of psoriasis vulgaris

H. Orzechowski, K. Reich, M. Sebastian, 2007, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Low N‐acetylating capacity in patients with Stevens‐Johnson syndrome and toxic epidermal necrolysis *

M. Mockenhaupt, J. Simon, B. Rzany, 1995, Experimental dermatology.

A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.

H. Gollnick, M. Meurer, D. Zillikens, 2006, Archives of dermatology.

A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus.

H. Gollnick, M. Meurer, T. Luger, 2006, Archives of dermatology.

Botulinum toxin in aesthetic applications: ‘How often misused words generate misleading thoughts’

B. Rzany, A. Pickett, 2009, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

S3 Guideline for the treatment of psoriasis vulgaris, update – Short version part 1 – Systemic treatment

K. Reich, M. Sebastian, M. Augustin, 2018, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Low prescription rate for systemic treatments in the management of severe psoriasis vulgaris and psoriatic arthritis in dermatological practices in Berlin and Brandenburg, Germany: results from a patient registry

A. Nast, S. Rosumeck, R. Erdmann, 2008, Journal of the European Academy of Dermatology and Venereology : JEADV.

Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens—Johnson syndrome and toxic epidermal necrolysis

J. Ring, M. Mockenhaupt, B. Rzany, 1996, The British journal of dermatology.

Peripheral Blood T-Cell Clonality in Mycosis Fungoides and Nonlymphoma Controls

J. Muche, A. Lukowsky, W. Sterry, 2003, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Increased risk of bullous pemphigoid in male and very old patients: A population-based study on incidence.

D. Zillikens, B. Rzany, B. Rzany, 1999, Journal of the American Academy of Dermatology.

Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age.

M. Meurer, D. Zillikens, M. Sticherling, 2002, Archives of dermatology.

Clinical characteristics of patients with repeated systemic reactions during specific immunotherapy with hymenoptera venoms

J. Ring, B. Wüthrich, P. Frosch, 1991, Allergy.

European Evidence-based (S3) Guideline for the Treatment of Acne

B. Dréno, A. Finlay, H. Gollnick, 2016 .

Interferential current is effective in palmar psoriaris: an open prospective trial.

G. Wolf, E. Jung, B. Rzany, 2000, European journal of dermatology : EJD.

Reproducibility of a four‐point clinical severity score for glabellar frown lines

W. Sterry, B. Rzany, P. Honeck, 2003, The British journal of dermatology.

Understanding, Avoiding, and Managing Severe Filler Complications

B. Rzany, C. Delorenzi, 2015, Plastic and reconstructive surgery.

Understanding , Avoiding , and Managing Severe Filler Complications FILLERS

B. Rzany, 2022 .

Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme.

R. Stern, L. Naldi, J. Roujeau, 1993, Archives of dermatology.

Stevens-Johnson syndrome after terbinafine therapy.

M. Mockenhaupt, B. Rzany, E. Schöpf, 1994, Journal of the American Academy of Dermatology.

S2k – Guideline on the Therapy of Acne

H. Gollnick, C. Bayerl, C. Zouboulis, 2010 .

Safety: Assessment and Treatment of Adverse Reactions

B. Rzany, 2014 .

Epidemiology of acne vulgaris

B. Rzany, C. Kahl, 2006, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.

R. Stern, L. Naldi, S. Shapiro, 1996, The New England journal of medicine.

Increased incidence of pemphigus vulgaris in southern Europeans living in Germany compared with native Germans

D. Zillikens, M. Amagai, B. Rzany, 2002, Journal of the European Academy of Dermatology and Venereology : JEADV.

[Clinical aspects and immunopathology in 48 patients with pemphigus].

E. Bröcker, D. Zillikens, M. Amagai, 2000, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

Three years after the publication of the German (S3) evidence based Psoriasis Guidelines – Was it worth the effort?

A. Nast, B. Rzany, 2009, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Do guidelines change the way we treat? Studying prescription behaviour among private practitioners before and after the publication of the German Psoriasis Guidelines

W. Sterry, A. Nast, R. Erdmann, 2009, Archives of Dermatological Research.

An open, multicentre, randomized clinical study in patients with bullous pemphigoid comparing methylprednisolone and azathioprine with methylprednisolone and dapsone

D. Zillikens, M. Sticherling, M. Hertl, 2017, The British journal of dermatology.

[Hyperhidrosis as risk factor for tinea pedis].

B. Rzany, R. Sinkgraven, I. Boboschko, 2005, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

Evidence‐based (S3) guideline for the treatment of androgenetic alopecia in women and in men

A. Tosti, A. Messenger, V. del Marmol, 2011, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

EVIDENCE BASED ( S 3 ) GUIDELINES FOR THE TREATMENT OF ANDROGENETIC ALOPECIA IN WOMEN AND IN MEN

A. Tosti, A. Messenger, R. Trüeb, 2011 .

PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

W. Sterry, A. Nast, B. Rzany, 2001 .

Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry.

M. Mockenhaupt, B. Rzany, B. Rzany, 1996, Journal of clinical epidemiology.

Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis

Theresa Anderson, Ariane Auquier, Berthold Rzany, 1995 .

Risk of Stevens-Johnson syndrome and toxic epider mal necrolysis during first weeks of antiepileptic therapy: a case-control study

L. Naldi, A. Auquier, J. Kelly, 1999, The Lancet.

Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions.

R. Stern, L. Naldi, A. Auquier, 1999, Lancet.

[Immunopathologic changes in 115 patients with bullous pemphigoid].

E. Bröcker, D. Zillikens, B. Rzany, 1999, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

Very low risk for ACE-inhibitors associated with Stevens-Johnson Syndrome and toxic epidermal necrolysis based on prescription data in defined daily doses

M. Mockenhaupt, N. Hollaender, B. Rzany, 1994 .

Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with the acquired immunodeficiency syndrome in Germany.

M. Mockenhaupt, B. Rzany, E. Schöpf, 1993, Archives of dermatology.

Interventions for excessive sweating of unknown cause

B. Rzany, A. Musekiwa, K. Shams, 2014 .

Diagnosis and Treatment of Melanoma. European Consensus ⴀbased Interdisciplinary Guideline Developed by the Guideline Subcommittee of the

A. Hauschild, J. Malvehy, H. Pehamberger, 2012 .

[Randomized, placebo-controlled, double blind clinical trial for the evaluation of the efficacy and safety of oral methantheliniumbromide (Vagantin) in the treatment of focal hyperhidrosis].

B. Rzany, R. Sinkgraven, M. Hund, 2004, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Efficacy and Safety of 3 New Resilient Hyaluronic Acid Fillers, Crosslinked With Decreased BDDE, for the Treatment of Dynamic Wrinkles: Results of an 18-Month, Randomized Controlled Trial Versus Already Available Comparators.

B. Rzany, N. Ribé, J. Larrouy, 2019, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Efficacy and durability of two hyaluronic acid-based fillers in the correction of nasolabial folds: results of a prospective, randomized, double-blind, actively controlled clinical pilot study.

A. Nast, D. Pathirana, R. Erdmann, 2011, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Injectable Fillers in Aesthetic Medicine

B. Rzany, M. Maio, 2006 .

Complications: How to Avoid and Treat Undesired Results

B. Rzany, 2009 .

Validated Composite Assessment Scales for the Global Face

J. Carruthers, M. Kerscher, G. Sattler, 2012, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[S3-Guidelines for the therapy of psoriasis vulgaris].

H. Orzechowski, K. Reich, M. Sebastian, 2006, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

59. Focal Hyperhidrosis

B. Rzany, K. Shams, 2014 .

Toxic epidermal necrolysis in patients receiving glucocorticosteroids.

B. Rzany, E. Schöpf, H. Schmitt, 1991, Acta dermato-venereologica.

An international collaborative case-control study of severe cutaneous adverse reactions (SCAR). Design and methods.

L. Naldi, S. Shapiro, A. Auquier, 1995, Journal of clinical epidemiology.

The Most Common Indications

B. Rzany, M. Maio, 2014 .

Assessment of publications using methods of evidence‐based medicine: an introduction using a dermatological clinical study

W. Boehncke, B. Rzany, Thomas A. Luger, 2007, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Head-to-head studies of botulinum toxin A in aesthetic medicine: which evidence is good enough?

A. Nast, B. Rzany, 2007, Journal of the American Academy of Dermatology.

Requirements and Rules

B. Rzany, M. Maio, 2014 .

The dermal type of erythema multiforme: a rare variant of Stevens-Johnson syndrome or cases of clinical misclassification?

M. Mockenhaupt, B. Rzany, E. Schöpf, 1997, Acta dermato-venereologica.

Update of the S1 guidelines on the definition and treatment of primary hyperhidrosis

M. Heckmann, B. Rzany, F. Bechara, 2018, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[Focal hyperhidrosis.Quality of life, socioeconomic importance and use of internal medicinal therapy].

B. Rzany, C. Müller, M. Hund, 2012, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

Evidence‐based (S3) guideline for the treatment of psoriasis vulgaris – Update: “Therapeutic options” and “Efalizumab”

K. Reich, M. Sebastian, M. Augustin, 2010 .

Evidence-based (S3) guideline for the treatment of psoriasis vulgaris - Update: "Therapeutic options" and "Efalizumab".

K. Reich, M. Sebastian, M. Augustin, 2010, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

The impact of adverse reactions to injectable filler substances on quality of life: results from the Berlin Injectable Filler Safety (IFS) – study

A. Nast, R. Erdmann, B. Rzany, 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

Psychosocial aspects of patients with focal hyperhidrosis. Marked reduction of social phobia, anxiety and depression and increased quality of life after treatment with botulinum toxin A

P. Elsner, M. Heckmann, B. Rzany, 2005, The British journal of dermatology.

Interferential Current in the Treatment of Palmar Psoriasis

G. Wolf, E. Jung, B. Rzany, 1999 .

Too many instruments for measuring Quality of Life in Atopic Dermatitis

B. Rzany, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

Acne treatment in the field: how guidelines and other sources can be included in daily practice

A. Nast, B. Rzany, 2013, Journal of the European Academy of Dermatology and Venereology.

Methods report on the development of the European S3 guidelines for the treatment of acne

A. Nast, B. Sporbeck, S. Rosumeck, 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

On the development of the European S3 guidelines on the systemic treatment of psoriasis vulgaris: structure and challenges

A. Ormerod, A. Nast, D. Pathirana, 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.

Advanced Indications and Techniques

B. Rzany, M. Maio, 2007 .

Chronic plaque psoriasis.

L. Naldi, B. Rzany, 2002, Clinical evidence.

S3 Guideline for the treatment of psoriasis vulgaris, update – Short version part 2 – Special patient populations and treatment situations

K. Reich, M. Sebastian, M. Augustin, 2018, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[S2k-guideline for therapy of acne].

H. Gollnick, C. Bayerl, C. Zouboulis, 2010, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[Oral anticholinergic therapy of focal hyperhidrosis with methanthelinium bromide (Vagantin). Initial data on effectiveness].

B. Rzany, M. Fuchslocher, 2002, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

Reply to Alberto Giannetti, MD, PhD commentary regarding the European S3‐Guidelines on the systemic treatment of Psoriasis

A. Nast, D. Pathirana, A. Sammain, 2010 .

Injizierbare Füllmaterialien

A. Nast, B. Rzany, F. Bachmann, 2013, Der Hautarzt.

E‐learning in the dermatological education at the Charité: evaluation of the last three years

Wolfram Sterry, Berthold Rzany, W. Sterry, 2008, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Online lectures for students in dermatology: A replacement for traditional teaching or a valuable addition?

W Sterry, W. Sterry, A. Nast, 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[Development of the evidence-based guidelines for psoriasis--a project of the German Dermatological Society (DDG)].

W. Sterry, M. Follmann, B. Rzany, 2005, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Incidence of Mild and Severe Skin Reactions Associated with the Use of Non-Steroidal Anti-Inflammatory Drugs

B. Rzany, E. Schöpf, 1992 .

S3 Guideline for the treatment of psoriasis vulgaris, update – Short version part 1 – Systemic treatment

K. Reich, M. Sebastian, M. Augustin, 2018, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Evidence Based Hair Restoration: Designing Clinical Trials

J. Shapiro, B. Rzany, A. Finner, 2006, International Society of Hair Restoration Surgery.

Stevens‐Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN): Evaluation for drug risk based on sale numbers in defined daily doses (DDD). Example of the H2‐antagonists

M. Mockenhaupt, B. Rzany, E. Schöpf, 1995 .

Recommendations for the best possible use of botulinum neurotoxin type a (Speywood units) for aesthetic applications.

Said Hilton, G. Sattler, B. Rzany, 2013, Journal of drugs in dermatology : JDD.